Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1984-04-10
1988-07-26
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
252106, 562471, 562587, A01N 5912, C11D 348, C07C 5948, C07C 5910
Patent
active
047599316
ABSTRACT:
Liquid iodophors are provided containing as surface-active agent a product of the formula RO--(C.sub.3 H.sub.6 O).sub.m --(C.sub.2 H.sub.4 O).sub.n --CH.sub.2 COOM, wherein RO is the residue of an alcohol of at least 8 carbon atoms or of an alkylphenol of at least 10 carbon atoms which is substantially free of olefinic unsaturation, m is a number having an average value of 0-10, n is a number having an average value of 2-20 and M is hydrogen or a monovalent cation. Preferably the iodophors contain at least 20% of iodine. The novel iodophors are prepared by dissolving at room temperature the desired amount of iodine in the surface-active agent.
REFERENCES:
patent: Re29909 (1979-02-01), Kurtz
patent: 2210874 (1940-08-01), Balle
patent: 2931777 (1960-05-01), Shelanski
patent: 2989434 (1961-06-01), Brost et al.
patent: 3438907 (1969-04-01), Schmolka
patent: 3983171 (1976-09-01), Vanlerberghe et al.
501 Stamicarbon B.V.
Kilcoyne John M.
Meyers Albert T.
LandOfFree
Novel liquid iodophors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel liquid iodophors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel liquid iodophors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-257164